United States · FDA National Drug Code directory

Benzonatate

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 62135-440_f8703b53-c89b-9014-e053-6294a90a4006
Product NDC: 62135-440
Form: CAPSULE
Composition / generic term: Benzonatate
Labeler: Chartwell RX, LLC
Marketing category: ANDA
Marketing start / end (source format): 20180501
Source listing expiry: 20261231

Source-listed ingredients

BENZONATATE — 100 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

100 CAPSULE in 1 BOTTLE (62135-440-01) · 62135-440-01
300 CAPSULE in 1 BOTTLE (62135-440-31) · 62135-440-31
90 CAPSULE in 1 BOTTLE (62135-440-90) · 62135-440-90

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →